Methode für die Kontrolle von chronischer Atmungskrankheit und nekrotischer Enteritis bei Vögeln

This invention provides a method for treating chronic respiratory disease, fowl cholera and necrotic enteritis in infected birds, by orally administering thereto a pharmaceutically effective amount of antibiotic LL-E19020 alpha , antibiotic LL-E19020 beta or a physiologically acceptable salt thereof...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: MAIESE, WILLIAM MICHAEL, BRIDGEWATER NEW JERSEY 08807, US, GREENSTEIN, MICHAEL, SUFFERN NEW YORK 10901, US, TESTA, RAYMOND THOMAS, CEDAR GROVE NEW JERSEY 07009, US, CARTER, GUY THOMAS, SUFFERN NEW YORK 10901, US, GOODMAN, JOSEPH JACOB, SPRING VALLEY NEW YORK 10977, US, BORDERS, DONALD BRUCE, SUFFERN NEW YORK 10901, US
Format: Patent
Sprache:ger
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:This invention provides a method for treating chronic respiratory disease, fowl cholera and necrotic enteritis in infected birds, by orally administering thereto a pharmaceutically effective amount of antibiotic LL-E19020 alpha , antibiotic LL-E19020 beta or a physiologically acceptable salt thereof. The physico-chemical characteristics of LL-E19020 alpha are as follows: Approximate elemental analysis : C 62.73; H 7.60; N1.00; 0 28.67 (by difference); Molecular weight: 1225 (FABMS); Apparent molecular formula: C65H95NO21; Specific rotation: [ alpha ]26_D = O (C 0.385, methanol); LL-E19020 beta Approximate elemental analysis: C 63.33; H 7.72; N 1.16; 0 27.79 (by difference); Molecular weight: 1225 (FABMS); Apparent molecular formula: C65H95NO21; Specific rotation: [ alpha ]26_D = -17+/-2(C 0.455, methanol);